17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease

Artamonova, 2007, Comparative genomics and evolution of alternative splicing: the pessimists' science, Chem. Rev., 107, 3407, 10.1021/cr068304c Barbieri, 2008, Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2, Endocrinology, 149, 4736, 10.1210/en.2007-1762 Biedler, 1973, Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture, Cancer Res., 33, 2643 Black, 2003, Mechanisms of alternative pre-messenger RNA splicing, Annu. Rev. Biochem., 72, 291, 10.1146/annurev.biochem.72.121801.161720 Bowery, 1993, GABAB receptor pharmacology, Annu. Rev. Pharmacol. Toxicol., 33, 109, 10.1146/annurev.pa.33.040193.000545 Castelnuovo, 2010, An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells, FASEB J., 24, 4033, 10.1096/fj.10-157032 Davies, 1993, CGP 55845A: a potent antagonist of GABAB receptors in the CA1 region of rat hippocampus, Neuropharmacology, 32, 1071, 10.1016/0028-3908(93)90073-C Dieci, 2007, The expanding RNA polymerase III transcriptome, Trends Genet., 23, 614, 10.1016/j.tig.2007.09.001 Einstein, 2008, Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors, Proc. Natl. Acad. Sci. U. S. A., 105, 5230, 10.1073/pnas.0801319105 Garcia-Blanco, 2004, Alternative splicing in disease and therapy, Nat. Biotechnol., 22, 535, 10.1038/nbt964 Johnson, 1990, Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease, Science, 248, 854, 10.1126/science.2111579 Pagano, 2007, New small nuclear RNA gene-like transcriptional units as sources of regulatory transcripts, PLoS Genet., 3, e1, 10.1371/journal.pgen.0030001 Robello, 1993, Regulation of GABAA receptor in cerebellar granule cells in culture: differential involvement of kinase activities, Neuroscience, 53, 131, 10.1016/0306-4522(93)90291-M Roberts, 2005, Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction, Physiol. Behav., 86, 18, 10.1016/j.physbeh.2005.06.017 Rogawski, 2003, The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease, CNS Drug Rev., 9, 275, 10.1111/j.1527-3458.2003.tb00254.x Seamon, 1986, Forskolin: its biological and chemical properties, Adv. Cyclic Nucleotide Protein Phosphor. Res., 20, 1 Selkoe, 1990, Deciphering Alzheimer's disease: the amyloid precursor protein yields new clues, Science, 248, 1058, 10.1126/science.2111582 Sun, 2007, Regulation by nicotine of Gpr51 and Ntrk2 expression in various rat brain regions, Neuropsychopharmacology, 32, 110, 10.1038/sj.npp.1301134 Wang, 2008, Alternative isoform regulation in human tissue transcriptomes, Nature, 456, 470, 10.1038/nature07509 Wilhelm, 2008, Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution, Nature, 453, 1239, 10.1038/nature07002 Wu, 2003, Novel small-molecule inhibitors of RNA polymerase III, Eukaryot. Cell, 2, 256, 10.1128/EC.2.2.256-264.2003